Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Arthrosin 250 tablets
1001010P0BDACAD
|
Arthrosin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrosin 500 tablets
1001010P0BDADAE
|
Arthrosin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrosin EC 250 tablets
1001010P0BDAFAH
|
Arthrosin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrosin EC 500 tablets
1001010P0BDAEAI
|
Arthrosin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.